Drug safety evaluation, also known as non-clinical drug safety evaluation, refers to the evaluation of the safety of therapeutic drugs through laboratory research and animal in vitro systems. It is a necessary procedure and important step before new drugs enter final clinical trials and final approval. . Drug safety must first be drafted protocols and protocols. These studies, such as general acute chronic toxicity studies, pathohistological studies, reproductive toxicity tests, genotoxicity studies, safety pharmacology studies, investigation studies, and toxicity and safety biomarker studies. Due to the volume of the very successful methods in the Molecular Biology series, the chapters include a brief introduction to the respective disciplines, a list of required materials, a step-by-step, repeatable protocol, and tips on troubleshooting and avoiding known pitfalls.

Market Analysis and Insights: Global Drug Safety Solutions and Pharmacovigilance Market
The global Drug Safety Solutions and Pharmacovigilance market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drug Safety Solutions and Pharmacovigilance market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drug Safety Solutions and Pharmacovigilance market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drug Safety Solutions and Pharmacovigilance market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drug Safety Solutions and Pharmacovigilance market.

Global Drug Safety Solutions and Pharmacovigilance Scope and Market Size
Drug Safety Solutions and Pharmacovigilance market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Drug Safety Solutions and Pharmacovigilance market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Standard Form
Customized Form

Segment by Application
Biotechnology and Pharmaceuticals
Contract Research Organization (CROS)
Hospital
KPO / BPO
Healthcare Institutions
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pharmaceutical Product Development, LLC
Drug Safety Solutions Limited
C3i
Worldwide Clinical Trials
Bioclinica
United Biosource LLC
Ennov
AB Cube
Covance Inc.
Accenture
PRA Health Sciences, Inc.
Ergomed
IQVIA
Genpact
Cognizant
Parexel International Corporation
ArisGlobal
ICON plc
Oracle
Syneos Health